Back to results
US 2026/0242746 A1Published application
Methods of cell preservation
AssigneeBe Biopharma, Inc.
InventorsMark Louis Lalli, Jordan Marie Smelker
Life of this patent
Estimating the term…
Abstract
The present disclosure provides methods and compositions for culturing, cryopreserving, and administering engineered B lineage cell populations. The methods and compositions are provided herein.
Claims26
A method of preparing a B lineage cell population for cryopreservation, the method comprising a step of:
- contacting the B lineage cell population with cryopreservation media comprising:
- about 4.5% to about 5% DMSO;
- and
- about 2.5% to about 10% HSA;
- thereby producing a cryopreservation cell preparation.
2 more elements
A composition comprising:
- (i) a population of frozen, genetically modified B lineage cells;
- and
- (ii) cryopreservation media comprising:
- about 4.5% to about 5% DMSO;
- and
- about 2.5% to about 10% HSA.
3 more elements
A method of treating a patient for a disease, wherein the method comprises administering a population of genetically modified B lineage cells that have been cryopreserved.
Dependencies are inferred from the claim text.